Assessment of artemisinin based combination therapy utilization among patent medicine vendors in some rural areas in Nigeria

International Journal of Collaborative Research on Internal Medicine and Public Health

Volumn 5, Issue 10, 2013, Pages 619-629

  Nduka, Sunday O ^a   Agbata, C A ^a   Eze, B H ^b   Ezeobi, I ^c   Nwadukwe, C C ^d   Uzodinma, S U ^a  

^a NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

^b Centre for Research on Population Studies and Development   (Nigeria)

^c ANAMBRA STATE UNIVERSITY   (Nigeria)

^d IGBINEDION UNIVERSITY   (Nigeria)

Author keywords

Antimalarias; Artemisinin combination therapy (ACT); Drug utilization; Nigeria; Patent medicine vendors (PMV); Rural area

Indexed keywords

EID: 84922106262     PISSN: None     EISSN: 18404529     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Onwujekwe O, Obikeze E, Uzochukwu BSC, Okoronkwo I and Onwujekwe C. Improving quality of malaria treatment services: assessing inequities in consumers' perceptions and providers' behaviour in Nigeria. Inter J for Equi in Health. 2010; 9:22.
2. Ajayi IO, Falade CO, Bamgboye EA, Oduola AMJ, Kale OO. Assessment of a treatment guideline to improve home management of malaria in children in rural south west Nigeria. Mal J. 2008; 7:24.
3. Federal Ministry of Health (FMOH). Malaria Control Policy. Document by Malaria Control Programme. 2004; Federal Ministry of Health, Abuja.
4. Pagnoni F, Kengeya KJ, Ridley R, et al. Artemisinin-based combination treatment in homebased management of malaria. Trop Med Int Health. 2005; 10:621-2.
5. Goodman C, Brieger W, Unwin A, Mills A, Meek S, and Greer G. "Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved?" Am J of Trop Med and Hyg. 2007; 77(6): 203-218.
6. Salako LA, Brieger WR, Afolabi BM, et al. Treatment of childhood fevers and other illnesses in three rural Nigerian communities. J Trop Pediat. 2001; 47:230-8.
7. Geissler PW, Nokes K, Prince RJ, Odhiambo RA, Aagaard-Hansen J, Ouma JH. Children and medicines: self-treatment of common illnesses among Luo schoolchildren in western Kenya. Soc Sci & Med. 2000; 50:1771-1783.
8. Gilpin U, Adedaji W, Nwokolo E, et al. Artemisinin Combination Therapy (ACTs): Improving management of malaria among patent medicine vendors (PMVs) in Lagos, Kano and Abia States, Nigeria. Society for Family Health, Sep, 2006. Technical Report.
9. Campbell MJ, Machin D. Medical Statistics: A common sense approach. 2nd ed. London: John Willey and Sons Ltd; 1996.
10. Outlet Survey Report (Baseline) Federal Republic of Nigeria. http://www.actwatch.info/downloads/results/68_result_Nigeria_Outlet_Baseline_ACTwatch _12-09.pdf. Accessed Febuary 28, 2013 by 14.38 hrs GMT
11. Egboh AA. Pharmacy laws and practice in Nigeria. Ikeja, Nigeria: Literamed Publications; 1984.
12. Oshiname FO, Brieger WR. Primary care training for patent medicine vendors in rural Nigeria. Soc Sci Med. 1992; 35:1477-84.
13. Aguwa EN, Aniebue PN and Obi IE. Management of childhood diarrhoea by patent medicine vendors in Enugu north local government area, Southeast Nigeria. Inter J of Med & Med Sci. 2010; 2(3): 88-93.
14. Brieger RW, Osamor PE, Salami KK, Oladepo O and Otusanya SA. Interactions between patent medicine vendors and customers in urban and rural Nigeria. Health Pol & Plan. 2004; 19(3): 177-182
15. Jimmy EO, Achelonu E, Orji S. Antimalarials' dispensing pattern by patent medicine dealers in rural settlements in Nigeria. Pub Health. 2000; 114: 282-5.
16. Tanner M and Vlassoff C. Treatment-seeking behaviour for malaria: a typology based on endemicity and gender. Soc Sci Med. 1998; 46(4-5):523-532.
17. Nuwaha F. "People's perception of malaria in Mbarara, Uganda" Trop Med & Inter Health. 2002; 7(5): 462-470.
18. Ahorlu K, Dunyo SK, Afari ES, Koram KA, and Nkrumah FK. Malaria related beliefs and behaviour in southern Ghana: implications for treatment, prevention and control. Trop Med and Inter Health 1997; 2(5):488-499.
19. Okeke TA and Okafor HU. Perception and Treatment Seeking Behavior for Malaria in Rural Nigeria: Implications for Control. J Hum Ecol. 2008; 24(3): 215-222.
20. World Health Organisation. Guidelines for the treatment of malaria www.who.int/malaria/docs/TreatmentGuildelines2006.pdf. Accessed January 25, 2013.
21. Gwer S, Newton C, Berkley JA. Over-diagnosis and co-morbidity of severe malaria in African children: a guide for clinicians. Am J Trop Med & Hyg. 2007; 77(6):6
22. Evans JA, Adusei A, Timmann C, et al. High mortality of infants bacteraemia clinically indistinguishable from severe malaria. QJM. 2004; 97(9):591-597
23. Ngasala BE. Improved malaria case management in under-fives in the era of artemisininbased combination therapy in Tanzania. http://publications.ki.se/xmlui/bitstream/handle/10616/38920/thesis.pdf?sequence=1. Published 2010. Accesses December 10, 2012 by 18.00hrs GMT
24. Jones G, Steketee RW, Black RE, Bhutta ZA. Child Survival Study Group: How many child deaths can we prevent this year? Lancet. 2003; 362:65-71.
25. Nketiah-Amponsah E. Mothers' Demand for Preventive Healthcare for Children Aged Under-Five Years: The Case of Utilization of Insecticide-Treated Bednets in Ghana. J Sust Dev. 2010; 3(2): 98-106
26. Falade CO, Yusuf B, Fadero FF, Mokuolu OA, Hamer DH, Salako LA. Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria. Malar J. 2007; 6:88
27. Legesse M and Deressa W. "Community awareness about malaria, its treatment and mosquito vector in rural highlands of central Ethiopia," Ethiopian J Health Dev. 2009; 23(1): 40-47.
28. Houmsou RS, Amuta EU, Sar TT. Malaria prevention during pregnancy: Awareness and factors contributing to disease occurrence among pregnant women in Gboko metropolis, Benue state, Nigeria. J Med & Biom Sci. 2010; 1(1): 36-40.
29. Abasiattai AM, Etukumana EA and Umoiyoho AJ. Awareness And Practice of Malaria Prevention Strategies Among Pregnant Women In Uyo, South South Nigeria. Inter J Gynecol &Obst. 2009; 11(1).
30. World Health Organization. Scaling Up Home Management of Malaria: From Research to Implementation. 2004; Geneva: World Health Organisation.
31. Akuse RM, Edwin E, Eseigbe EE, Abubakar AA and Brieger WR. Patent Medicine Sellers: How Can They Help Control Childhood Malaria? Malar Res Treat. 2010. Article ID 470754, 7 pages.
32. Umar MT, Chika A and Jimoh AO. Compliance of Primary Health Care Providers to Recommendation of Artemesinin-Based Combination Therapy in the Treatment of Uncomplicated Malaria in Selected Primary Health Care Centres in Sokoto, North Western Nigeria. Inter J Trop Med. 2011; 6(3): 70-7.
33. Adisa R, Fakeye TO and Dike D. Evaluation of Adverse Drug Reactions to Artemisininbased Combination Therapy in a Nigeria University Community. Trop J Pharm Res. 2008; 7(2): 937-944.
34. Mangham LJ, Cundill B, Ezeoke O, et al. Treatment of uncomplicated malaria at public health facilities and medicine retailers in southeastern Nigeria. Malar J. 2010; 10:155
35. Dodoo ANO, Fogg C, Asiimwe A, et al. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy. Malar J. 2009; 8:2.
36. Anberber S, Tessema T and Yimer A. Severe malaria in the under-fives--clinical featrues, management and outcome in a district hospital. Ethiop Med J. 2003; 41(4):301-10
37. Idro R, Aloy J, Mayende L, Bitarakwate E, John CC and Kivumbi GW. Severe malaria in children in areas with low, moderate and high transmission intensity in Uganda. Trop Med & Inter Health.2006; 11(1): 115-124.
38. Onwujekwe O, Uzochukwu B, Dike N, Uguru N, Nwobi E, Shu E. Malaria treatment perceptions, practices and influences on provider behaviour: comparing hospitals and nonhospitals in south-east Nigeria. Malar J. 2009; 8:246.
39. Okeke TA, Uzochukwu BSC, Okafor HU. An in-depth study of patent medicine sellers' perspectives on malaria in a rural Nigerian community. Malar J. 2006; 5:97
40. Igboeli N, Ukwe CV, Ekwunife OI. Increasing use of artemisinin-based combination therapy for treatment of malaria infection in Nigerian hospitals. 2010; 8(4):243-249. http://www.pharmacypractice.org. Accessed January 25, 2013.
41. Tavrow P, Shabahang J, Makama S. Changing harmful treatment practices among private drug sellers in rural Kenya: Results of a vendor-to-vendor intervention. The 129th Annual Meeting of the American Public Health Association: Atlanta, USA; 2001.
42. Asante KP, Owusu R, Dosoo D, et al. Adherence to Artesunate-Amodiaquine Therapy for Uncomplicated Malaria in Rural Ghana: A Randomised Trial of Supervised versus Unsupervised Drug Administration. J Trop Med. 2009. Article ID 529583, 7 pages
43. Ishola IO, Oreagba IA, Olayemi SO and Gbadamosi R. Assessment of treatment pattern of uncomplicated malaria in peadiatric patients attending a teaching hospital in North West Nigeria. J Appl Pharma Sci. 2011; 01(05): 177-181.
44. Ezzet F, van Vugt M, Nosten F, Looareesuwan S, White NJ. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob Ags Chemother. 2000; 44: 697-704.
45. Fogg C, Bajunirwe F, Piola P, et al. Adherence to a six-dose regimen of artemetherlumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J Trop Med Hyg. 2004; 71:525-530.